TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Antibody titers and CD8 T cells producing IFNγ and TNFα
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Severe laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: 1-repetition maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in OHIP-14 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Rate of intraoperative nausea and vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of uterine atony
Endpoint domain: Adverse events/effects
Primary endpoint: Time to the first recognized bowel movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Re-epithelialization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration from beginning therapy until vaginal delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of recurrent RTIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Days of absence from day-care
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Working days lost by parents
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: IC at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: headache relief at 30 minutes post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AMH levels at 3 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: LH levels at 3 months postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: salpingectomy operating time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of nights zolpidem was chosen
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total number of capsules self‐administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average nightly dose self‐administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: need for postoperative ibuprofen
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: incidence of OCR
Endpoint domain: Adverse events/effects
Primary endpoint: PROM scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tolerance to ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease of PaCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: S100B blood levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: MCA PI values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Insulin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PON1 protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PON1‐associated specific activities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PON3 protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lymph drainage time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total amount of lymphorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: overall incidence of major events
Endpoint domain: Mortality/survival
Primary endpoint: ultrasonographic clot volume score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of reviews
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Masking success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with a reduction of 3 or more points by VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Children's anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mothers' anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mothers' satisfaction with the program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Learning potential
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Immediate memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Logic memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Bacteremia after biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Dysuria after biopsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: faster parasite clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: odds of having a PC½ of ≥5 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parasitemia 3 days after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum cholinesterase activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total atropine dosage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacterial survival
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: change in LV end-diastolic volume (LVEDV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Somatization levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain-related distress
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total IPSS from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in QoL from baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Attitude towards Evidence-Based Medicine (EBM)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mortality within three months
Endpoint domain: Mortality/survival
Primary endpoint: Voice quality ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stage 3 NREM sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Viral load <50 copies per milliliter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion of retinol-binding protein and beta-2 microglobulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Liking for the drink
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Arteriolar tortuosity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arteriolar length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arteriolar diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative proportion of patients with erosive esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Resolution of heartburn, acid regurgitation, and epigastric pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Need for additional anesthetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA disease-free survival (PSA-DFS)
Endpoint domain: Mortality/survival
Primary endpoint: plasma norepinephrine concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of caesarean sections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Blood Alcohol Concentration (BAC) estimation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gadolinium-enhancing lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Interferon-related side effects
Endpoint domain: Adverse events/effects
Primary endpoint: sputum volume expectorated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Heart rates and blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postoperative analgesia requests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of LV myocardial mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intraoperative transfusion of PRBCs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: FFP transfusion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet concentrates transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cumulative probability of developing MS by 15 years
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in serum retinol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of children with inadequate liver vitamin A stores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: execution time of intracorporeal suture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specific and general quality-of-life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: topical corticosteroid use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SCORAD geometric mean ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: claimed handicaps
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: fewer unicursal tasks solved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reinforced responding for video reward
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAQ and EuroQoL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Premature birth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: hemodynamic changes following intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: mean RPP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: RFD0-100 ms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RFD0-200 ms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RFDpeak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean electromyographic amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height Velocity (HV) increases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height standard deviation scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of outpatient attendances
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: emergency admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Physical health-related quality of life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mental health-related quality of life (HRQOL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction in pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of multifollicular development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence of multiple pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: rest energy expenditure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with care planning process
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Recall of care plans
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Half-life of the active metabolite OR-1896
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pressure ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parenchymal thickness measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: exocrine insufficiency prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with phlebitis
Endpoint domain: Adverse events/effects
Primary endpoint: Steroid-free clinical remission at week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery of braking capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical working capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hemodynamics improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parenchymal hemorrhage within the first 7 days
Endpoint domain: Adverse events/effects
Primary endpoint: Mean hepatic enhancement (MHE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak enhancement value (PEV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery rate at 8 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: articulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial glycaemic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: confirmed MR(4.5)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CA19-9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fasting VLDL triglyceride levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: TDRM prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Bladder Volume (BV) measurement accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in pelvic organ mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximal regurgitant jet area (JA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: vena contracta (VC) width
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: proximal isovelocity surface area (PISA) radius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3-year body weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of saliva markers (sIgA and albumin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bone density after extraction and 6 months after surgical treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reflux symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Cough/phlegm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: 11-dehydro-TXB(2) urinary excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 8-iso-PGF(2alpha) urinary excretion rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in DVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation proctitis incidence
Endpoint domain: Adverse events/effects
Primary endpoint: MEND (Mean Naproxen Equivalent Daily Dose)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hepatic enhancement (ΔHU > 50HU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean SpO2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: onset of anesthesia and analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: duration of anesthesia and analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Activities of Daily Living
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood loss > 1000 ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Push-out bond strength of All Bond 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: water diffusion measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: BMI-Z growth rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Language and literacy scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical efficacy at the end of treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfactory bacteriologic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of major adverse cardiac event
Endpoint domain: Mortality/survival
Primary endpoint: Recovery of liver function tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: First-phase insulin secretion response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Second-phase insulin secretion response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 2-h plasma glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FSSG score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: serum cPSA concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: tPSA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: fPSA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Hypoparathyroidism-related hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Hypoparathyroidism-related emergency room visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of outpatient visits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: insomnia severity index scores
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: ischemic stroke/systemic embolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mental health scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EDSS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accrued weeks of remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants in remission at week 36 and week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SDMT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: non-AIDS events
Endpoint domain: Mortality/survival
Primary endpoint: Safety profile of lodenafil carbonate
Endpoint domain: Adverse events/effects
Primary endpoint: Mean pharmacokinetic parameters (tmax and t1/2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroconversion to positive antibody to HBeAg (anti‐HBe)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Total number of albuterol treatments administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Measurement of CCD with US
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of US in classifying hip joint synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of US in classifying hip joint synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coronary venous levels of CD41-positive polymorphonuclear leukocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: percent difference in estimated energy intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of ARIA‐E/H on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes